Acadia Pharmaceuticals (ACAD) Other Accumulated Expenses (2011 - 2026)
Acadia Pharmaceuticals (ACAD) reported Other Accumulated Expenses of $15.96 million for Q2 2026, up 19.1% from $13.4 million a year earlier but down 1.0% from the prior quarter.
Acadia Pharmaceuticals (ACAD) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025, Acadia Pharmaceuticals posted Other Accumulated Expenses of $5.89 million, up 73.8% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of 2.9% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $3.39 million in FY2024 (-69.3%), $11.04 million in FY2023 (+307.5%), $2.71 million in FY2022 (+0.8%) and $2.69 million in FY2021 (-47.5%).
- Five-year quarterly Other Accumulated Expenses spans a low of $986,000 in Q2 2022 and a high of $16.12 million in Q1 2026.
- Year over year, Other Accumulated Expenses has now increased in each of the last three quarters, with growth averaging 12.1% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q1 2023 (growth of 777.8%); the low point was Q4 2024 (a decline of 69.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $16.12 million (Q1 2026), $5.89 million (Q4 2025) and $5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.95 Bn | 1,100.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.80 Bn | 555.66 Bn | 17.30 Bn |
| 3 | AbbVie | 506.62 Bn | 479.73 Bn | 12.70 Bn |
| 4 | Merck | 358.64 Bn | 313.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.18 Bn | 256.17 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.70 Bn | 239.39 Bn | 12.86 Bn |
| 7 | Amgen | 237.74 Bn | 193.14 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.25 Bn | 169.45 Bn | 6.22 Bn |
| 9 | Pfizer | 171.25 Bn | 117.90 Bn | 10.94 Bn |
| 10 | Acadia Pharmaceuticals | 3.38 Bn | -93.20 Mn | 279.64 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.96 Mn |
| Mar 31, 2026 | 16.12 Mn |
| Dec 31, 2025 | 5.89 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 13.40 Mn |
| Mar 31, 2025 | 9.35 Mn |
| Dec 31, 2024 | 3.39 Mn |
| Sep 30, 2024 | 12.72 Mn |
| Jun 30, 2024 | 8.88 Mn |
| Mar 31, 2024 | 13.74 Mn |
| Dec 31, 2023 | 11.04 Mn |
| Sep 30, 2023 | 8.95 Mn |
| Jun 30, 2023 | 5.89 Mn |
| Mar 31, 2023 | 10.26 Mn |
| Dec 31, 2022 | 2.71 Mn |
| Sep 30, 2022 | 2.52 Mn |
| Jun 30, 2022 | 986,000.00 |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 2.69 Mn |
| Sep 30, 2021 | 2.76 Mn |
Acadia Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACAD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();